These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35328214)

  • 1. Urinary Activin A: A Novel Biomarker for Human Acute Kidney Injury.
    Nagayama I; Maeshima A; Nagata D
    Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Urinary Activin A as a Novel Biomarker Reflecting the Severity of Acute Kidney Injury.
    Takahashi S; Nakasatomi M; Takei Y; Ikeuchi H; Sakairi T; Kaneko Y; Hiromura K; Nojima Y; Maeshima A
    Sci Rep; 2018 Mar; 8(1):5176. PubMed ID: 29581558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Utility of Urinary Follistatin as a Non-Invasive Indicator of Acute Tubular Damage in Patients with Acute Kidney Injury.
    Nagayama I; Takayanagi K; Nagata D; Hasegawa H; Maeshima A
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubule-Derived Follistatin Is Increased in the Urine of Rats with Renal Ischemia and Reflects the Severity of Acute Tubular Damage.
    Nagayama I; Takayanagi K; Hasegawa H; Maeshima A
    Cells; 2023 Mar; 12(5):. PubMed ID: 36899937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the activin-follistatin system in tubular regeneration after renal ischemia in rats.
    Maeshima A; Zhang YQ; Nojima Y; Naruse T; Kojima I
    J Am Soc Nephrol; 2001 Aug; 12(8):1685-1695. PubMed ID: 11461941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activin A: a novel urinary biomarker of renal impairment in multiple myeloma.
    Iriuchishima H; Maeshima A; Takahashi S; Ishizaki T; Yokohama A; Tsukamoto N; Saitoh T; Murakami H; Handa H
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31072919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follistatin, an activin antagonist, ameliorates renal interstitial fibrosis in a rat model of unilateral ureteral obstruction.
    Maeshima A; Mishima K; Yamashita S; Nakasatomi M; Miya M; Sakurai N; Sakairi T; Ikeuchi H; Hiromura K; Hasegawa Y; Kojima I; Nojima Y
    Biomed Res Int; 2014; 2014():376191. PubMed ID: 24883308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Activin A is a novel biomarker reflecting renal inflammation and tubular damage in ANCA-associated vasculitis.
    Takei Y; Takahashi S; Nakasatomi M; Sakairi T; Ikeuchi H; Kaneko Y; Hiromura K; Nojima Y; Maeshima A
    PLoS One; 2019; 14(10):e0223703. PubMed ID: 31613925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Epidermal Growth Factor Level as a Noninvasive Indicator of Tubular Repair in Patients with Acute Kidney Injury.
    Ono K; Maeshima A; Nagayama I; Kubo T; Yagisawa T; Nagata D
    Diagnostics (Basel); 2024 Apr; 14(9):. PubMed ID: 38732362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gremlin1 and TGF-β1 protect kidney tubular epithelial cells from ischemia-reperfusion injury through different pathways.
    Gao X; Han L; Yao X; Ma L
    Int Urol Nephrol; 2022 Jun; 54(6):1311-1321. PubMed ID: 34633599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the activin-follistatin system in the developmental and regeneration processes of the kidney.
    Maeshima A; Nojima Y; Kojima I
    Cytokine Growth Factor Rev; 2001 Dec; 12(4):289-98. PubMed ID: 11544099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Pax-2 in the action of activin A on tubular cell regeneration.
    Maeshima A; Maeshima K; Nojima Y; Kojima I
    J Am Soc Nephrol; 2002 Dec; 13(12):2850-9. PubMed ID: 12444203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary metabolites predict mortality or need for renal replacement therapy after combat injury.
    Gisewhite S; Stewart IJ; Beilman G; Lusczek E
    Crit Care; 2021 Mar; 25(1):119. PubMed ID: 33757577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation Study.
    McMahon BA; Galligan M; Redahan L; Martin T; Meaney E; Cotter EJ; Murphy N; Hannon C; Doran P; Marsh B; Nichol A; Murray PT
    Am J Nephrol; 2019; 50(1):19-28. PubMed ID: 31203271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
    Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
    Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice.
    Kadiombo AT; Maeshima A; Kayakabe K; Ikeuchi H; Sakairi T; Kaneko Y; Hiromura K; Nojima Y
    Am J Physiol Renal Physiol; 2017 Feb; 312(2):F297-F304. PubMed ID: 27881396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on biomarkers of acute kidney injury: moving closer to clinical impact?
    Schiffl H; Lang SM
    Mol Diagn Ther; 2012 Aug; 16(4):199-207. PubMed ID: 22650449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of urinary midkine as a biomarker in patients with acute kidney injury.
    Hayashi H; Sato W; Kosugi T; Nishimura K; Sugiyama D; Asano N; Ikematsu S; Komori K; Nishiwaki K; Kadomatsu K; Matsuo S; Maruyama S; Yuzawa Y
    Clin Exp Nephrol; 2017 Aug; 21(4):597-607. PubMed ID: 27530994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac biomarkers are associated with maximum stage of acute kidney injury in critically ill patients: a prospective analysis.
    Haines R; Crichton S; Wilson J; Treacher D; Ostermann M
    Crit Care; 2017 Apr; 21(1):88. PubMed ID: 28399905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil activation in septic acute kidney injury: A post hoc analysis of the FINNAKI study.
    Törnblom S; Nisula S; Vaara ST; Poukkanen M; Andersson S; Pettilä V; Pesonen E
    Acta Anaesthesiol Scand; 2019 Nov; 63(10):1390-1397. PubMed ID: 31325317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.